Hologic — Jul 30, 2025 release
Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001140361-25-028008
Showing in the filing
GAAP EPS Reported % Increase (Decrease)
“(22.9%) to (22.0%)”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 25
Organic, constant currency revenue growth ex… for Q4 FY2025
“mid-single-digit growth”
Organic, constant currency revenue growth ex… for Q4 FY2025
“mid-single-digit growth”
Non-GAAP earnings per share growth relative … for Q4 FY2025
“will grow faster than revenue”
Non-GAAP tax rate for FY2025
“approximately 19.25%”
Non-GAAP tax rate assumption for FY2025
“approximately 19.25%”
Diluted shares outstanding for FY2025
“approximately 228 million”
Diluted shares outstanding assumption for FY2025
“approximately 228 million”
Revenue for FY2025
“$4,081 - $4,091”
Revenue Reported % Increase (Decrease) for FY2025
“1.3% to 1.5%”
Revenue Constant Currency % Increase (Decrea… for FY2025
“1.1% to 1.4%”
Revenue Organic % Increase (Decrease) for FY2025
“(0.5%) to (0.2%)”
Revenue Organic excluding COVID-19 % Increas… for FY2025
“0.6% to 0.8%”
GAAP EPS for FY2025
“$2.56 - $2.59”
GAAP EPS Reported % Increase (Decrease) for FY2025
“(22.9%) to (22.0%)”
Non-GAAP EPS for FY2025
“$4.23 - $4.26”
Non-GAAP EPS Reported % Increase (Decrease) for FY2025
“3.7% to 4.4%”
Revenue for Q4 FY2025
“$1,030 - $1,040”
Revenue Reported % Increase (Decrease) for Q4 FY2025
“4.3% to 5.3%”
Revenue Constant Currency % Increase (Decrea… for Q4 FY2025
“3.7% to 4.7%”
Revenue Organic % Increase (Decrease) for Q4 FY2025
“2.7% to 3.7%”
Revenue Organic excluding COVID-19 % Increas… for Q4 FY2025
“3.9% to 5.0%”
GAAP EPS for Q4 FY2025
“$0.90 - $0.93”
GAAP EPS, Reported % Increase (Decrease) for Q4 FY2025
“18.4% to 22.4%”
Non-GAAP EPS for Q4 FY2025
“$1.09 - $1.12”
Non-GAAP EPS, Reported % Increase (Decrease) for Q4 FY2025
“7.9% to 10.9%”
Exhibit 99.1 · the passage around this item
… earlier in the release
Current Guidance
Previous
Guidance
Guidance $
Reported %
Increase
(Decrease)
Constant
Currency %
Increase
(Decrease)
Organic %
Increase
(Decrease)
Organic
excluding
COVID-19 %
Increase
(Decrease)
Guidance $
Fiscal 2025
Revenue
$4,081 - $4,091
1.3% to 1.5%
1.1% to 1.4%
(0.5%) to (0.2%)
0.6% to 0.8%
$
4,050 - $4,100
GAAP EPS
$2.56 - $2.59
(22.9%) to (22.0%)
$
2.47 - $2.57
Non-GAAP EPS
$4.23 - $4.26
3.7% to 4.4%
$
4.15 - $4.25
Q4 2025
Revenue
$1,030 - $1,040
4.3% to 5.3%
3.7% to 4.7%
2.7% to 3.7%
3.9% to 5.0%
GAAP EPS
$0.90 - $0.93
18.4% to 22.4%
Non-GAAP EPS
$1.09 - $1.12
7.9% to 10.9%
3
Use of Non-GAAP Financial Measures
The Company has presented the following non-GAAP financial measures in this press release: constant currency revenues; organic revenues; organic revenues excluding
COVID-19; non-GAAP gross margin; non-GAAP operating expenses; non-GAAP operating margin; non-GAAP effective tax rate; non-GAAP net income; non-GAAP net income margin; non-GAAP EPS; adjusted EBITDA; adjusted net leverage ratio and adjusted ROIC.
Organic revenue for the fiscal third quarter of 2025 excludes the diveste
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.